The CASTLE study is focused on rolandic epilepsy which is the most common type of epilepsy – affecting about one-sixth of all children with epilepsy in the UK – that means over 10,000 people! We use the simple term “rolandic epilepsy” although you may also hear it referred to as “benign rolandic epilepsy” or “benign childhood epilepsy with centrotemporal spikes.” Children with rolandic epilepsy find that their learning, sleep, behaviour, self-esteem and mood are also often affected, and the condition can cause stress in the family.
The CASTLE Study programme of research led by Prof Deb Pal at Kings College London and Prof Paul Gringras at Evelina London Children’s Hospital, with a large team of clinical and scientific experts as well as parents and young people. The study will receive £2.3 million in funding.
What we are doing?
Treating epilepsy with drugs to reduce seizures has been the traditional goal of medical treatment. However, just reducing seizures doesn’t necessarily make much difference to the way children and parents feel. The drugs used to treat epilepsy often slow down a patient’s thinking and learning. Experts used to believe this was an acceptable price to pay to reduce seizures. However, with rolandic epilepsy where children ‘grow out’ of their seizures in teenage years, we don’t know if is better to treat these children with drugs or not, especially if this might have a negative effect on their learning. This is something that parents are also very concerned about.
In order to address these uncertainties, we will work with children, parents, doctors and nurses to choose the best ways to measure health and quality of life for children with epilepsy. Then we will compare three groups of children: those on the standard drug treatment, those taking a newer drug that doesn’t impact on thinking and learning as much, and those on no drug treatment. We will examine which is best to improve children’s health and quality of life.
The CASTLE Study will also include talking to parents and children about their experiences in relation to sleep, taking medication, learning and how taking part in the study has impacted on them. Two parents of children with epilepsy will advise on the study throughout its duration and a team of researchers will work with parents and children to learn about their experiences.
Most children with epilepsy have sleep problems and wake in the night. Disturbed sleep in turn reduces learning ability and can also trigger seizures. Parents often get up to check on their child in case s/he is having a seizure, and sometimes sleep with the child because they are worried. This can make the parent very tired the next day, and affect their stress and concentration levels. We will adapt an existing sleep behavioural treatment to the sleep problems experienced by parents of children with epilepsy. Then we will test how well it works compared to standard treatment in a randomised controlled trial.
To guide, inform and support all of this research, children with rolandic epilepsy and parents of children with rolandic epilepsy will have an opportunity to play a meaningful role in the research process.
Who is conducting the research?
The CASTLE Study is led by Prof Deb Pal at Kings College London and Prof Paul Gringras at Evelina London Children’s Hospital, with a large team of clinical and scientific experts as well as parents and young people. The study will receive £2.3 million in funding.
Who has reviewed this study?
CASTLE clinical trial is now ready to launch! All necessary initial approvals (Ethical, MHRA and HRA)|for the study have been received and we intend to begin recruitment in June.
Take part in the this study
The CASTLE clinical trial is now ready to launch! Recruitment will occur across years 2-4 of the trial,
beginning in June 2019. Please contact firstname.lastname@example.org if you would like more information